Challenges and Learning: First Experience of Photopheresis in a Child with Graft-versus-Host Disease
Desafíos y aprendizaje: primera experiencia de fotoféresis en un niño con enfermedad de injerto contra receptor
How to Cite
Download Citation

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Show authors biography
Graft-versus-Host Disease (GVHD) is a serious and common complication following allogeneic hematopoietic stem cell transplants (allo-HSCT), accounting for approximately 25% of post-transplant deaths. Its incidence, which has increased over the past two decades, reaches around 50% in patients undergoing allogeneic hematopoietic progenitor cell transplants. Factors such as patient age, the use of unrelated donors, reduced-intensity regimens, and specific sources of stem cells contribute to this increase. Initial treatment involves corticosteroids and calcineurin inhibitors, but in refractory cases, extracorporeal photopheresis (ECP) emerges as an option. Clinical case: We present the case of a pediatric patient undergoing haploidentical allogeneic hematopoietic progenitor cell transplant for severe aplastic anemia, who subsequently developed severe refractory chronic GVHD, with severe liver, skin and mild lung involvement, who underwent extracorporeal photopheresis sessions as part of the second line of GVHD treatment, with a partial response. Conclusion: the approach and treatment of GVHD results in the impossibility of a single treatment for all patients with this pathology.
Article visits 300 | PDF visits 190
Downloads
- Grube M, Holler E, Weber D, Holler B, Herr W, Wolff D. Risk factors and outcome of chronic graft-versus-host disease after allogeneic stem cell transplantation-results from a single-center observational study. Biol Blood Marrow Transplant [Internet]. 2016;22(10):1781-91. Disponible en: http://dx.doi.org/10.1016/j.bbmt.2016.06.020 DOI: https://doi.org/10.1016/j.bbmt.2016.06.020
- Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, et al. Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: A report from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant [Internet]. 2015;21(2):266-74. Disponible en: http://dx.doi.org/10.1016/j.bbmt.2014.10.021 DOI: https://doi.org/10.1016/j.bbmt.2014.10.021
- Baird K, Cooke K, Schultz KR. Chronic graft-versus-host disease (GVHD) in children. Pediatr Clin North Am [Internet]. 2010;57(1):297-322. Disponible en: http://dx.doi.org/10.1016/j.pcl.2009.11.003 DOI: https://doi.org/10.1016/j.pcl.2009.11.003
- Haroun E, Agrawal K, Leibovitch J, Kassab J, Zoghbi M, Dutta D, et al. Chronic graft-versus-host disease in pediatric patients: Differences and challenges. Blood Rev [Internet]. 2023;60(101054):101054. Disponible en: http://dx.doi.org/10.1016/j.blre.2023.101054 DOI: https://doi.org/10.1016/j.blre.2023.101054
- Choi SW, Levine JE, Ferrara JLM. Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin North Am [Internet]. 2010;30(1):75-101. Disponible en: http://dx.doi.org/10.1016/j.iac.2009.10.001 DOI: https://doi.org/10.1016/j.iac.2009.10.001
- Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report. Biol Blood Marrow Transplant [Internet]. 2005;11(12):945-56. Disponible en: http://dx.doi.org/10.1016/j.bbmt.2005.09.004 DOI: https://doi.org/10.1016/j.bbmt.2005.09.004
- Jagasia M, Greinix H, Arora M, Williams K, Wolff D, Cowen E, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. the 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant [Internet]. 2015;21(3):389-401.e1. Disponible en: http://dx.doi.org/10.1016/j.bbmt.2014.12.001 DOI: https://doi.org/10.1016/j.bbmt.2014.12.001
- Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th ed. Cham (CH): Springer; 2019. Disponible en http://dx.doi.org/10.1007/978-3-030-02278-5 DOI: https://doi.org/10.1007/978-3-030-02278-5
- Defilipp Z, Alousi AM, Pidala JA, Carpenter PA, Onstad LE, Arai S. Non relapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the chronic GVHD consortium Blood Adv. Blood Adv. 2021;5:4278-84. Disponible en: https://doi.org/10.1182/bloodadvances.2021004941 DOI: https://doi.org/10.1182/bloodadvances.2021004941
- Nygaard M, Wichert S, Berlin G, Toss F. Extracorporeal photopheresis for graft-vs-host disease: A literature review and treatment guidelines proposed by the Nordic ECP Quality Group. Eur J Haematol [Internet]. 2020;104(5):361-75. Disponible en: http://dx.doi.org/10.1111/ejh.13381 DOI: https://doi.org/10.1111/ejh.13381
- Drexler B, Buser A, Infanti L, Stehle G, Halter J, Holbro A. Extracorporeal photopheresis in graft-versus-host disease. Transfus Med Hemother [Internet]. 2020;47(3):214-25. Disponible en: http://dx.doi.org/10.1159/000508169 DOI: https://doi.org/10.1159/000508169
- Calore E, Marson P, Pillon M, Tumino M, Tison T, Mainardi C, et al. Treatment of acute graft-versus-host disease in childhood with extracorporeal photochemotherapy/photopheresis: The padova experience. Biol Blood Marrow Transplant [Internet]. 2015;21(11):1963-72. Disponible en: http://dx.doi.org/10.1016/j.bbmt.2015.07.007 DOI: https://doi.org/10.1016/j.bbmt.2015.07.007
- Asensi Cantó P, Sanz Caballer J, Solves Alcaína P, de la Rubia Comos J, Gómez Seguí I. Extracorporeal photopheresis in graft-versus-host disease. Transplant Cell Ther [Internet]. 2023;29(9):556-66. Disponible en: http://dx.doi.org/10.1016/j.jtct.2023.07.001 DOI: https://doi.org/10.1016/j.jtct.2023.07.001
- Pierelli L, Perseghin P, Marchetti M, Messina C, Perotti C, Mazzoni A, et al. Extracorporeal photopheresis for the treatment of acute and chronic graft‐versus‐host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Transplantation (GITMO) consensus process. Transfusion [Internet]. 2013;53(10):2340-52. Disponible en: http://dx.doi.org/10.1111/trf.12059 DOI: https://doi.org/10.1111/trf.12059
- Qayed M, Wang T, Hemmer M, Spellman S, Arora M, Couriel D, et al. Influence of age on acute and chronic GVHD in children undergoing HLA-identical sibling bone marrow transplantation for acute leukemia: Implications for prophylaxis. Biol Blood Marrow Transplant [Internet]. 2018;24(3):521-8. Disponible en: http://dx.doi.org/10.1016/j.bbmt.2017.11.004 DOI: https://doi.org/10.1016/j.bbmt.2017.11.004
- Chang Y-J, Wu D-P, Lai Y-R, Liu Q-F, Sun Y-Q, Hu J, et al. Antithymocyte globulin for matched sibling donor transplantation in patients with hematologic malignancies: A multicenter, open-label, randomized controlled study. J Clin Oncol [Internet]. 2020;38(29):3367-76. Disponible en: http://dx.doi.org/10.1200/JCO.20.00150 DOI: https://doi.org/10.1200/JCO.20.00150
- Kozlov A, Estrina M, Paina O, Bykova T, Osipova A, Kozhokar P, et al. Extracorporeal photopheresis in children with chronic graft-versus-host disease. Pharmaceuticals (Basel) [Internet]. 2021;14(8):808. Disponible en: http://dx.doi.org/10.3390/ph14080808 DOI: https://doi.org/10.3390/ph14080808
